跳至主要内容
临床试验/NCT04110743
NCT04110743已完成不适用

EXPLORER PET/CT: A Pilot Evaluation in Healthy Volunteers

University of California, Davis2 个研究点 分布在 1 个国家目标入组 30 人开始时间: 2019年6月19日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
30
试验地点
2
主要终点
Standardized Uptake Value SUV(t)= C(t)/ID/BW; C(t) is Radioactivity Measured at the Time t, Decay Corrected to t=0 and Converted From a Volume to a Mass Based Unit Via the Factor 1/(1 g/mL); ID: the Injected Dose at t=0; W= Body Weight; SUV is Correct UM

研究概览

简要总结

The objective of this pilot study is to collect preliminary data using total body scans on a new, first of its kind, FDA 510k-cleared positron emission tomography/computed tomography (PET/CT) scanner, called EXPLORER.

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Parallel
主要目的
Basic Science
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Men and women, 18 years of age or older
  • Willing and able to fast for at least 6 hours before and for the duration of the scan
  • Willing and able to lay motionless in a supine position for 60 and 20 minutes at separate timepoints.
  • Willing and able to give informed consent

排除标准

  • No Primary Care Physician
  • Body weight >240 kg
  • Allergy to iodine contrast (only for subjects enrolled in Arm 3)
  • Creatinine levels > 1.5 mg/dL or estimated glomerular filtration rate (eGFR) < 60 ml/minute (only for subjects enrolled in Arm 3)
  • Recent (1 month) contrast enhanced CT
  • Any known concomitant acute infection (including upper respiratory infection, genitourinary infections, etc.
  • History of metastatic or newly (last 5 years) diagnosed locally invasive cancer.
  • Chemotherapy in the last 5 years
  • Radiation therapy in the last 3 years
  • Major surgery within the last 6 months.
  • Pregnancy or breast-feeding
  • Fasting blood glucose level > 160 mg/dL before administration of FDG
  • Prisoners
  • The standard MRI contraindications apply, including but not limited to:
  • Having a pacemaker or other implanted electronic device. Metal foreign bodies, aneurysm clips, heart valve prosthesis, vascular stents, cochlear implants, embolization coils, gunshot wounds with retained bullet fragments, penile implant, IUCD.
  • Claustrophobia

结局指标

主要结局

Standardized Uptake Value SUV(t)= C(t)/ID/BW; C(t) is Radioactivity Measured at the Time t, Decay Corrected to t=0 and Converted From a Volume to a Mass Based Unit Via the Factor 1/(1 g/mL); ID: the Injected Dose at t=0; W= Body Weight; SUV is Correct UM

时间窗: approximatively 12 hours for Arm 1 only

To collect preliminary data regarding FDG biodistribution in the organs listed as a function of time of 12 hours. Time-activity curves will be created

Coefficient of Variation. SD/Mean (Standard Deviation Divided by Mean Value)

时间窗: approximatively 6 hours for Arm 1 only

To obtain preliminary data regarding low dose EXPLORER noise level

Standardized Uptake Value

时间窗: approximatively 90 minutes

To collect preliminary data about total body FDG perfusion and early biodistribution. Time-activity curves will be created

Standardized Uptake Value SUV(t)= C(t)/(ID/BW); C(t) is Radioactivity Measured From at Time t, Decay Corrected to t=0-converted From a Volume to a Mass Based Unit Via the Factor 1/(1 g/mL); ID: the Injected Dose at t=0; BW= Body Weight; SUV is Correct UM

时间窗: approximatively 3 hours

To obtain preliminary data to understand whether intravenous iodinated contrast agent produce a significant change in quantification of FDG uptake levels. Time/activity curves will be generated.

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验